Evidence: The science largely supports the findings described, however the title misleadingly implies a causal effect ("Weight loss drug Ozempic cuts depression, anxiety, and addiction risk") but the article itself is more nuanced and emphasises associations rather than using causal language ("GLP-1 medications...may also be linked to better mental health outcomes").

Balance: The article is unbiased.

Clarity: Overall, a clear summary however it could have been improved by making clear the within-individual design, i.e., that the authors of the study compared periods of use versus periods of non-use of a medication in the same individual.